1-3 of 3
Frank Hilberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo

Viktoria Laszlo, Zsuzsanna Valko, Ildiko Kovacs, Judit Ozsvar, Mir Alireza Hoda, Thomas Klikovits, Dora Lakatos, Andras Czirok, Tamas Garay, Alexander Stiglbauer, Thomas H. Helbich, Marion Gröger, Jozsef Tovari, Walter Klepetko, Christine Pirker, Michael Grusch, Walter Berger, Frank Hilberg, Balazs Hegedus, Balazs Dome
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3729–3740.
https://doi.org/10.1158/1078-0432.CCR-17-1507
Published: 31 July 2018
View articletitled, Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo
Open the PDF for Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo in another window
Includes: Multimedia, Supplementary data
Journal Articles

Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model

Ruben Bill, Ernesta Fagiani, Adrian Zumsteg, Helena Antoniadis, David Johansson, Simon Haefliger, Imke Albrecht, Frank Hilberg, Gerhard Christofori
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (21): 4856–4867.
https://doi.org/10.1158/1078-0432.CCR-14-3036
Published: 01 November 2015
View articletitled, Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model
Open the PDF for Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model in another window
Includes: Supplementary data
Journal Articles

Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3–Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma

Guido Bisping, Doris Wenning, Martin Kropff, Dirk Gustavus, Carsten Müller-Tidow, Matthias Stelljes, Gerd Munzert, Frank Hilberg, Gerald J. Roth, Martin Stefanic, Sarah Volpert, Rolf M. Mesters, Wolfgang E. Berdel, Joachim Kienast
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (2): 520–531.
https://doi.org/10.1158/1078-0432.CCR-08-1612
Published: 15 January 2009
View articletitled, Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3–Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma
Open the PDF for Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3–Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma in another window